Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Adv Exp Med Biol. 2016;886:171–189. doi: 10.1007/978-94-017-7417-8_9

Fig. 9.1.

Fig. 9.1

miRNAs and their validated targets in endometrial and endometriotic tissue. Left table summarizes miR-NAs and their predicted transcript/protein in endometrial tissue (indicated as the gray lining of the uterus in the figure) derived from studies incorporating human endometrial cells which have been validated. Right table summarizes miRNAs and their predicted transcript/protein in endometriotic tissue (indicated as red ectopic tissue in the figure) derived from studies incorporating human cells which have been validated. Superscripts refer to references with a = Petracco et al. 2011; b = Hawkins et al. 2011; c = Abe et al. 2013; d = Dai et al. 2012; e = Shen et al. 2013; f = Adammek et al. 2013. Validation refers to either assessing cellular events and/or mRNA and protein levels by modulation of endogenous miRNA levels